| 1 |
interferon
(23018 times)
|
Allergy and Immunology
(5376 times)
|
IL (5813 times)
TNF (2880 times)
HCV (1642 times)
|
1980 Effect of interferon-alpha 1 from E. coli on some cell functions.
|
| 2 |
interferon-alpha
(527 times)
|
Neoplasms
(172 times)
|
HCV (65 times)
CML (50 times)
IL-2 (26 times)
|
1983 Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity.
|
| 3 |
interferon-gamma
(194 times)
|
Allergy and Immunology
(44 times)
|
TNF (62 times)
LPS (29 times)
IL (26 times)
|
1985 Synergistic interaction of a cytokine produced by embryonic fibroblasts and a lymphokine contained in Con A-stimulated spleen cell culture for murine macrophage differentiation: a model experiment using cell line cells, M1.
|
| 4 |
gamma-interferon
(85 times)
|
Allergy and Immunology
(16 times)
|
TNF (17 times)
IL (10 times)
LPS (9 times)
|
1984 Interferon production in primary immunodeficiencies.
|
| 5 |
IFN-gamma
(70 times)
|
Allergy and Immunology
(35 times)
|
IFNs (19 times)
iNOS (4 times)
GAS (3 times)
|
1981 Effect of interferon on antibody formation.
|
| 6 |
IFN-alpha
(43 times)
|
Virology
(14 times)
|
IFNs (8 times)
DC (3 times)
HIV-1 (3 times)
|
1981 Lymphokine production by PHA-stimulated human lymphocytes is enhanced by interferon.
|
| 7 |
IFN-beta
(29 times)
|
Virology
(16 times)
|
IRF3 (4 times)
RIG-I (3 times)
ISGs (2 times)
|
1981 Lymphokine production by PHA-stimulated human lymphocytes is enhanced by interferon.
|
| 8 |
IFN-alpha and IFN-beta
(19 times)
|
Allergy and Immunology
(9 times)
|
DCs (2 times)
dpi (2 times)
STING (2 times)
|
1992 Two distinct pathways of interferon induction as revealed by 2-aminopurine.
|
| 9 |
IFN-alphabeta
(19 times)
|
Allergy and Immunology
(16 times)
|
DCs (6 times)
ODNs (2 times)
pDCs (2 times)
|
1996 Overexpression of c-Fos induces apoptosis of CD43+ pro-B cells.
|
| 10 |
IFN-lamda
(19 times)
|
Allergy and Immunology
(4 times)
|
IFNs (3 times)
HSV-1 (2 times)
RSK1 (2 times)
|
2007 Human primary immunodeficiencies of type I interferons.
|
| 11 |
interferon-alpha and -gamma
(11 times)
|
Allergy and Immunology
(6 times)
|
NK (3 times)
IL-2 (2 times)
ara-C (1 time)
|
1984 Defective interferon-gamma production in ataxia-telangiectasia.
|
| 12 |
TLR3-interferon
(10 times)
|
Therapeutics
(2 times)
|
IL (3 times)
AAD (1 time)
Ad (1 time)
|
2004 Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.
|
| 13 |
infundibular nucleus
(9 times)
|
Metabolism
(3 times)
|
PVN (6 times)
NPY (2 times)
AgRP (1 time)
|
1986 Regional distribution of gastrin-releasing peptide- and somatostatin-like immunoreactivity in the rabbit hypothalamus.
|
| 14 |
interferon beta-1a
(8 times)
|
Neurology
(3 times)
|
GA (5 times)
DMT (2 times)
MSFC (2 times)
|
2011 Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
|
| 15 |
pegylated-interferon
(8 times)
|
Gastroenterology
(4 times)
|
HCV (3 times)
SVR (3 times)
ACR (1 time)
|
2004 Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension.
|
| 16 |
interferon production
(5 times)
|
Allergy and Immunology
(5 times)
|
CMI (1 time)
DAPK1 (1 time)
EZ (1 time)
|
1984 Effect of verapamil on interferon production, mastocyte degranulation and histamine release--studies in mice sensitized with ovalbumin.
|
| 17 |
interferon therapy
(4 times)
|
Gastroenterology
(2 times)
|
HCV (3 times)
HCC (2 times)
Ab (1 time)
|
1991 Treatment of chronic non-A, non-B hepatitis with interferon.
|
| 18 |
pegylated-interferon alpha
(4 times)
|
Chemistry, Pharmaceutical
(1 time)
|
RBV (2 times)
CPPs (1 time)
DAA (1 time)
|
2011 Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.
|
| 19 |
(peg)-Interferon
(3 times)
|
Gastroenterology
(2 times)
|
PEG (3 times)
CHB (1 time)
HCV (1 time)
|
2014 [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
|
| 20 |
IFN-beta and IFN-alpha
(3 times)
|
Genomics
(1 time)
|
AI (1 time)
DEF (1 time)
dRIG-I (1 time)
|
2011 Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
|
| 21 |
increased numbers of interferon
(3 times)
|
Natural Science Disciplines
(2 times)
|
DC (1 time)
IL-28A (1 time)
NK (1 time)
|
2017 Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-gamma.
|
| 22 |
infliximab
(3 times)
|
Rheumatic Diseases
(2 times)
|
ADA (3 times)
ETN (3 times)
RA (2 times)
|
2012 Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis.
|
| 23 |
interferon beta treatment
(3 times)
|
Allergy and Immunology
(1 time)
|
a-IFN (1 time)
CCR (1 time)
CM (1 time)
|
2004 Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C.
|
| 24 |
interferon-based
(3 times)
|
Gastroenterology
(2 times)
|
DAA (2 times)
HCV (2 times)
SVR (2 times)
|
2016 Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.
|
| 25 |
retinoid-interferon
(3 times)
|
Reproductive Medicine
(2 times)
|
VEGF (2 times)
IHC (1 time)
MMP (1 time)
|
2014 Expression of GRIM-19 in missed abortion and possible pathogenesis.
|
| 26 |
IFN group
(2 times)
|
Gastroenterology
(2 times)
|
123I-BMIPP (1 time)
AFP (1 time)
ECG (1 time)
|
2000 Early diagnosis of interferon-induced myocardial disorder in patients with chronic hepatitis C: evaluation by myocardial imaging with 123I-BMIPP.
|
| 27 |
IFN-alpha or beta
(2 times)
|
Pathology
(2 times)
|
SMC (1 time)
|
1981 Effect of interferon on antibody formation.
|
| 28 |
increased following interferon
(2 times)
|
Molecular Biology
(1 time)
|
AQP (1 time)
IL (1 time)
miRs (1 time)
|
2014 Therapeutic effect of Zeng Ye decoction on primary Sjogren's syndrome via upregulation of aquaporin‑1 and aquaporin‑5 expression levels.
|
| 29 |
increased nuclear translocation of interferon
(2 times)
|
Tropical Medicine
(1 time)
|
BMDCs (1 time)
DCs (1 time)
HMGN1 or N1 (1 time)
|
2011 Activation of the innate immune response against DENV in normal non-transformed human fibroblasts.
|
| 30 |
induced for interferon
(2 times)
|
Allergy and Immunology
(1 time)
|
Con A (1 time)
IHN (1 time)
IHNV (1 time)
|
1997 Isoprinosine and levamisole as stimulators of interferon production in blood leukocytes of patients with alcoholic liver cirrhosis.
|
| 31 |
infection following Interferon
(2 times)
|
Pediatrics
(1 time)
|
HCV (2 times)
DAA (1 time)
ISG (1 time)
|
2015 The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist.
|
| 32 |
interfascicular neuron
(2 times)
|
Brain
(1 time)
|
AC (1 time)
CC (1 time)
PC (1 time)
|
2002 Histological and ultrastructural characterization of interfascicular neurons in the rat anterior commissure.
|
| 33 |
interferon activity
(2 times)
|
Brain
(1 time)
|
Con A (1 time)
PBMC (1 time)
SSPE (1 time)
|
1983 Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.
|
| 34 |
interferon response
(2 times)
|
Proteins
(1 time)
|
CC (1 time)
Ery (1 time)
INFL (1 time)
|
2020 Definition of erythroid cell-positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection.
|
| 35 |
interferon status
(2 times)
|
Zoology
(1 time)
|
AA (1 time)
CON (1 time)
COX (1 time)
|
1993 [The dynamic production of interferons, interleukins and arachidonic acid metabolites by the blood cells of children with glomerulonephritis associated with HB virus infection while treated with reaferon].
|
| 36 |
interferon system
(2 times)
|
Virology
(1 time)
|
AR (1 time)
BA (1 time)
RNAi (1 time)
|
2012 [Evaluation of the interferon system and major cytokines in patients with bronchial asthma].
|
| 37 |
interferon type I
(2 times)
|
Neoplasms
(1 time)
|
FISH (1 time)
IL-17A (1 time)
PBMCs (1 time)
|
1995 Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization.
|
| 38 |
interferon-alpha therapy
(2 times)
|
Cardiology
(1 time)
|
HCV (1 time)
SUD (1 time)
SUDs (1 time)
|
2001 Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: relation between exercise hyperemia and endothelial function.
|
| 39 |
isoformononetin
(2 times)
|
Biochemistry
(1 time)
|
DZN (1 time)
EQL (1 time)
|
2019 LC-ESI-MS/MS method for the simultaneous determination of isoformononetin, daidzein, and equol in rat plasma: Application to a preclinical pharmacokinetic study.
|
| 40 |
type-1-interferon
(2 times)
|
Allergy and Immunology
(2 times)
|
TNF (1 time)
|
1999 Bovine monocytoid cells transformed to proliferate cease to exhibit lineage-specific functions.
|
| 41 |
ABZ-interferon
(1 time)
|
Parasitology
(1 time)
|
ABZ (1 time)
CE (1 time)
|
2016 In vivo evaluation of the efficacy of combined albedazole-IFN-alpha treatment for cystic echinococcosis in mice.
|
| 42 |
alpha-IFN
(1 time)
|
Neurology
(1 time)
|
MS (1 time)
RR (1 time)
|
2003 [Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis].
|
| 43 |
cAMP-induced NK suppression and interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
cAMP (1 time)
NK (1 time)
PGE1 (1 time)
|
1983 Inhibition of human NK cell cytotoxicity by induction of cyclic AMP depends on impaired target cell recognition.
|
| 44 |
cytokines-interferon
(1 time)
|
Medicine
(1 time)
|
CAG (1 time)
GAC (1 time)
IL (1 time)
|
2016 Local Immune Response in Helicobacter pylori Infection.
|
| 45 |
DAV-interferon
(1 time)
|
Dermatology
(1 time)
|
VCR (1 time)
|
2012 Postoperative DAV-IFN-beta therapy does not improve survival rates of stage II and stage III melanoma patients significantly.
|
| 46 |
families-interferon
(1 time)
|
Antineoplastic Agents
(1 time)
|
TRAIL (1 time)
|
2011 A 71-gene signature of TRAIL sensitivity in cancer cells.
|
| 47 |
Fe-inefficient
(1 time)
|
Plant Physiological Phenomena
(1 time)
|
EF (1 time)
IDC (1 time)
VCR (1 time)
|
2017 Insights into Resistance to Fe Deficiency Stress from a Comparative Study of In Vitro-Selected Novel Fe-Efficient and Fe-Inefficient Potato Plants.
|
| 48 |
fish, interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
EMSA (1 time)
qRT-PCR (1 time)
|
2019 Interferon regulatory factor 2 plays a positive role in interferon gamma expression in golden pompano, Trachinotus ovatus (Linnaeus 1758).
|
| 49 |
i.e. for interferon
(1 time)
|
General Surgery
(1 time)
|
AP (1 time)
CD (1 time)
CP (1 time)
|
2003 Immunological findings in acute and chronic pancreatitis.
|
| 50 |
ice freezing nuclei
(1 time)
|
|
---
|
2020 Persistent Supercooled Drizzle at Temperatures below -25C Observed at McMurdo Station, Antarctica.
|
| 51 |
idiopathic facial nerve/Bell's palsy
(1 time)
|
General Surgery
(1 time)
|
ARS (1 time)
OCSs (1 time)
OtoHNS (1 time)
|
2016 Oral corticosteroid prescribing habits of Canadian Otolaryngologist-Head and Neck Surgeons.
|
| 52 |
ifenprodil
(1 time)
|
Neurology
(1 time)
|
AMPAR (1 time)
ANI (1 time)
BLA (1 time)
|
2016 Involvement of protein phosphatases in the destabilization of methamphetamine-associated contextual memory.
|
| 53 |
IFN responsive genes
(1 time)
|
Biotechnology
(1 time)
|
MSTN (1 time)
RNAi (1 time)
SCNT (1 time)
|
2015 Effect of Co-transfection of Anti-myostatin shRNA Constructs in Caprine Fetal Fibroblast Cells.
|
| 54 |
IFN, and who were treated with combination therapy
(1 time)
|
Drug Therapy
(1 time)
|
---
|
2000 [Early prediction of lack of response to treatment with interferon and interferon plus ribavirin using biochemical and virological criteria in patients with chronic hepatitis C].
|
| 55 |
IFN-alpha, IFN-beta, and IFN-gamma
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1988 Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism.
|
| 56 |
IFN-alpha, IFN-beta, and MxA
(1 time)
|
Virology
(1 time)
|
huTRIM5alpha (1 time)
IFNs (1 time)
MxA (1 time)
|
2010 Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
|
| 57 |
IFN-alpha-, adaptive cytokines - interferon
(1 time)
|
Gastroenterology
(1 time)
|
CD (1 time)
G-CSF (1 time)
GM-CSF (1 time)
|
2016 Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease.
|
| 58 |
IFN-based therapy
(1 time)
|
Virology
(1 time)
|
HCV (1 time)
IFN-lamda3 (1 time)
SVR (1 time)
|
2014 Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.
|
| 59 |
IFN-DCs
(1 time)
|
Allergy and Immunology
(1 time)
|
DCs (1 time)
|
2003 Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
|
| 60 |
IFN-free regimens
(1 time)
|
Rheumatology
(1 time)
|
CV (1 time)
DAAs (1 time)
HCV (1 time)
|
2015 HCV Treatments and Their Integration Into Rheumatology.
|
| 61 |
IFN-g
(1 time)
|
Pharmacology
(1 time)
|
IFNs (1 time)
|
1999 Interferons and their role In inflammation.
|
| 62 |
IFN-I and IFN-III
(1 time)
|
Virology
(1 time)
|
GPC (1 time)
ISG (1 time)
ISRE (1 time)
|
2021 Interactions of Viral Proteins from Pathogenic and Low or Non-Pathogenic Orthohantaviruses with Human Type I Interferon Signaling.
|
| 63 |
IFN-I or IFN-alphabeta
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
2005 Depletion of T cells by type I interferon: differences between young and aged mice.
|
| 64 |
IFN-III or IFN-lamda
(1 time)
|
Virology
(1 time)
|
DENV (1 time)
DENV-2 (1 time)
ISGs (1 time)
|
2015 Interferon lambda inhibits dengue virus replication in epithelial cells.
|
| 65 |
IFN-Le
(1 time)
|
Hematology
(1 time)
|
CSF (1 time)
|
1984 The effects of interferon on granulopoiesis in vitro.
|
| 66 |
IFNalpha alone
(1 time)
|
Neoplasms
(1 time)
|
CI (1 time)
HGF (1 time)
mRCC (1 time)
|
2021 Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).
|
| 67 |
IFNaR
(1 time)
|
Molecular Biology
(1 time)
|
AAV (1 time)
cDCs (1 time)
NK (1 time)
|
2019 Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells.
|
| 68 |
IFNG gene encoding interferon
(1 time)
|
Medicine
(1 time)
|
CAA (1 time)
CAL (1 time)
IVIG (1 time)
|
2016 Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.
|
| 69 |
IL-23 facilitates interferon
(1 time)
|
Acquired Immunodeficiency Syndrome
(1 time)
|
HCV (1 time)
IL (1 time)
ISGs (1 time)
|
2014 Inteleukin-23 promotes interferon-alpha responsiveness in hepatitis C virus/HIV-coinfected patients.
|
| 70 |
IL-27 treated DCs showed no up-regulation of Type I
(1 time)
|
Medicine
(1 time)
|
DCs (1 time)
iDCs (1 time)
mDCs (1 time)
|
2013 Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway.
|
| 71 |
IL-28, Fas, Fas ligand, interferon
(1 time)
|
Communicable Diseases
(1 time)
|
ATL (1 time)
CNS (1 time)
HAM (1 time)
|
2021 Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.
|
| 72 |
IL-6, neutrophil elastase and interferon
(1 time)
|
Dermatology
(1 time)
|
IL (1 time)
TNF (1 time)
|
2000 Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumour necrosis factor-alpha stimulate its secretion in vitro.
|
| 73 |
imatinib+interferon
(1 time)
|
Neoplasms
(1 time)
|
CML (1 time)
|
2014 Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib.
|
| 74 |
immune functions of IL-27, interferon
(1 time)
|
Complementary Therapies
(1 time)
|
IL (1 time)
MPE (1 time)
STAT (1 time)
|
2015 Immune Regulation of Interleukin-27 in Malignant Pleural Effusion.
|
| 75 |
immune-regulatory functions including interferon
(1 time)
|
Molecular Biology
(1 time)
|
CTL (1 time)
EBNA1 (1 time)
EBV (1 time)
|
2002 Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
|
| 76 |
immunity as well as the release of cytokines
(1 time)
|
Allergy and Immunology
(1 time)
|
PRL (1 time)
|
1995 Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women.
|
| 77 |
immunoassay for interferon
(1 time)
|
Dermatology
(1 time)
|
IL (1 time)
Mtb (1 time)
TST (1 time)
|
2009 Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
|
| 78 |
immunofluorescent nanosphere
(1 time)
|
Chemistry Techniques, Analytical
(1 time)
|
CRP (1 time)
FN (1 time)
FNs (1 time)
|
2016 Sensitive and Quantitative Detection of C-Reaction Protein Based on Immunofluorescent Nanospheres Coupled with Lateral Flow Test Strip.
|
| 79 |
immunoregulatory function of interferon
(1 time)
|
|
EAE (1 time)
IBD (1 time)
MS (1 time)
|
2016 IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.
|
| 80 |
immunospot-interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
BP (1 time)
HLA (1 time)
HPV-16 (1 time)
|
2009 Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins.
|
| 81 |
impact of treatment
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2004 Risk factors for liver fibrosis progression in patients with chronic hepatitis C.
|
| 82 |
impaired NK-cell functions, including interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
CHB (1 time)
DiD (1 time)
HBV (1 time)
|
2016 Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.
|
| 83 |
important for type I interferon
(1 time)
|
Virology
(1 time)
|
NPs (1 time)
PICV (1 time)
RNase (1 time)
|
2015 In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions.
|
| 84 |
Importantly, NKp46-CD8alphaalpha-Ly49E+ cells produce interferon
(1 time)
|
Biological Science Disciplines
(1 time)
|
ILC1 (1 time)
NK (1 time)
|
2017 A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties.
|
| 85 |
in situ formation/release of interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
GM-CSF (1 time)
IL (1 time)
TNF (1 time)
|
2014 Acacia ferruginea inhibits cyclophosphamide-induced immunosuppression and urotoxicity by modulating cytokines in mice.
|
| 86 |
in vitro for human leucocyte interferon
(1 time)
|
Hematology
(1 time)
|
HTCA (1 time)
MM (1 time)
|
1985 Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma.
|
| 87 |
in vitro, fucoidan amplified interferon
(1 time)
|
Genetics, Medical
(1 time)
|
IL (1 time)
LAB (1 time)
|
2011 A sulfated polysaccharide, fucoidan, enhances the immunomodulatory effects of lactic acid bacteria.
|
| 88 |
includes the production of antiviral
(1 time)
|
Allergy and Immunology
(1 time)
|
IFNs (1 time)
PAMPs (1 time)
SOCS (1 time)
|
2008 Interferons: signaling, antiviral and viral evasion.
|
| 89 |
including non-pegylated ('standard') interferon alfa
(1 time)
|
Health Services Research
(1 time)
|
ADV (1 time)
CHB (1 time)
HRQoL (1 time)
|
2006 Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
|
| 90 |
incorporation following stimulation with interferon
(1 time)
|
Hematology
(1 time)
|
CLL (1 time)
|
1986 Interferon induces proliferation in leukemic and normal B-cell subsets.
|
| 91 |
increased frequency of interferon
(1 time)
|
Communicable Diseases
(1 time)
|
HIV (1 time)
|
2011 Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.
|
| 92 |
increased NF-kappaB activity and interferon
(1 time)
|
Veterinary Medicine
(1 time)
|
duTRAF3 (1 time)
PBMCs (1 time)
TRAF3 (1 time)
|
2019 Molecular cloning and functional characterisation of duck (Anas platyrhynchos) tumour necrosis factor receptor-associated factor 3.
|
| 93 |
indicating decreased quality of life
(1 time)
|
Public Health
(1 time)
|
DAAs (1 time)
HCV (1 time)
HRQoL (1 time)
|
2018 Evaluation of health status in patients with hepatitis c treated with and without interferon.
|
| 94 |
indistinguishable from gamma interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
PMA (1 time)
|
1982 Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
|
| 95 |
induced neither interferon
(1 time)
|
Allergy and Immunology
(1 time)
|
HCV (1 time)
HD (1 time)
TNF (1 time)
|
2013 Hepatitis C patients on maintenance hemodialysis show complex immune disturbances in the peripheral blood.
|
| 96 |
inducible HO-1 mRNA by LPS or LPS+interferon
(1 time)
|
Biochemistry
(1 time)
|
HO-1 (1 time)
iNOS (1 time)
LPS (1 time)
|
2015 Nitric oxide is an important regulator of heme oxygenase-1 expression in the lipopolysaccharide and interferon-gamma-treated murine macrophage-like cell line J774.1/JA-4.
|
| 97 |
inducible nitrite synthase (iNOS), interferon
(1 time)
|
Veterinary Medicine
(1 time)
|
AGP (1 time)
CER (1 time)
FM (1 time)
|
2009 Effects of dietary glycine supplementation and fish meal on inflammatory responses in broiler chicks.
|
| 98 |
inducible NO synthase, interferon
(1 time)
|
Nutritional Sciences
(1 time)
|
CER (1 time)
Glu (1 time)
Gly (1 time)
|
2008 Dietary supplementation of glycine modulates inflammatory response indicators in broiler chickens.
|
| 99 |
inducing several hundred cellular genes, aptly named 'interferon
(1 time)
|
Virology
(1 time)
|
NS (1 time)
PVM (1 time)
RSV (1 time)
|
2017 The nonstructural proteins of Pneumoviruses are remarkably distinct in substrate diversity and specificity.
|
| 100 |
infected newborn mice with interferon-alpha
(1 time)
|
General Surgery
(1 time)
|
EHBA (1 time)
RRV (1 time)
|
1998 Progress in developing animal models for biliary atresia.
|
A Search Service for Abbreviation / Long Form